A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors

By  

Medicinal Chemistry, Vol. 9, Iss. 3, 2013-01 ,pp. : 360-370

Bentham Science Publishers

Access to resources Recommend Favorite

Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia

By Yan Lin   Colandrea Vincent J   Hale Jeffrey J  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. : 1219-1245

Informa Healthcare

Access to resources Recommend Favorite

HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting

By  

Current Pharmaceutical Design, Vol. 15, Iss. 33, 2009-11 ,pp. : 3886-3894

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based drug design for hypoxia-inducible factor prolyl-hydroxylase inhibitors and its therapeutic potential for the treatment of erythropoiesis-stimulating agent-resistant anemia: raising expectations for exploratory clinical trials

By Higashijima Yoshiki   Tanaka Tetsuhiro   Nangaku Masaomi  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. : 965-976

Informa Healthcare

Access to resources Recommend Favorite

HIF Prolyl 4-Hydroxylases and their Potential as Drug Targets

By  

Current Pharmaceutical Design, Vol. 15, Iss. 33, 2009-11 ,pp. : 3878-3885

Bentham Science Publishers

Access to resources Recommend Favorite